Navigation Links
Microbia PE Adds Nutritional Ingredient Industry Veteran Charles Walton to Senior Management Team
Date:1/12/2009

LEXINGTON, Mass., Jan. 12 /PRNewswire/ -- Microbia Precision Engineering, Inc. (Microbia) announced today that Charles Wesley Walton has joined the company as Director of North American Sales. In this newly created position, Mr. Walton will be responsible for developing and maintaining business accounts and building customer relationships across North America.

"Chuck Walton is a highly experienced veteran of the food and nutritional supplement industries with an exceptional 25-year sales and marketing record that epitomizes Microbia's hallmark traits: Passion, innovation, and the drive to excel," said Richard Bailey, Ph.D., CEO of Microbia. "We are delighted to have Chuck join our ranks, and we look forward to his contributions as we take full advantage of the company's scientific leadership to shape the future of Microbia and bring important new bio-based products to market."

"This is an exciting time to join Microbia as momentum builds for the company," said Mr. Walton. "With its unique approach to metabolic pathway engineering, Microbia has made impressive progress over the past several years in building a company that is well-positioned to capitalize on the tremendous promises of industrial biotechnology. The Microbia team has done an outstanding job of ensuring that the company is ready to build on its technology and business opportunities, and I look forward to accelerating that momentum as we focus on commercializing the company's initial carotenoid products and expanding pipeline of bioproducts and materials."

Chuck Walton's experience in senior-level sales and marketing, product development, and strategic planning positions with food and nutritional supplements companies spans more than 20 years. Before joining Microbia, Mr. Walton was Executive Vice President and a co-founder of Attitude Drink Company, for which he created the IQZOL and Vis Viva brands and managed product development. Prior to that, he served as Director of Product Development and Innovation for Bravo! Brands, after serving 17 years with DSM Nutritional products (formerly Roche Vitamins, Inc.). At Roche Vitamins, Mr. Walton was a Senior Account Manager and a major contributor to product design and new product introductions specializing in the food and beverage industry representing more than $30 million in revenue. At DSM Nutritional, Mr. Walton received five President's Achievement awards for outstanding sales and three top supplier awards from major food and beverage manufacturers. Mr. Walton holds a B.S. in Marketing and Business Administration from Saint Cloud State University.

ABOUT MICROBIA PE (http://www.microbia-pe.com)

Microbia is an industrial biotechnology company applying proprietary metabolic engineering approaches to create novel, commercially valuable specialty ingredients and biomaterials. Microbia's products are generated from renewable raw materials and either replace existing petrochemical-derived counterparts in a cost-effective manner, or introduce new industrial chemicals with applications as novel biomaterials. Microbia is commercializing its technology through internal product development programs as well as strategic alliances, including an ongoing multiproduct joint development and commercialization agreement with Tate & Lyle Investments, Ltd. Microbia was established in 2006 as a majority-owned subsidiary of Ironwood Pharmaceuticals, Inc. and is based in Lexington, Massachusetts.

     Contact:
     Mary Moynihan
     M2Friend Biocommunications
     802.951.9600
     mary@m2friend.com

'/>"/>
SOURCE Microbia
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. Microbia PE Bolsters Senior Management Team; Positions Company for Commercializing Proprietary Bioproducts
2. New Online Tutorial for the Comprehensive Microbial Resource (CMR)
3. PURE Bioscience and Ciba Strike New Contract for Natural Antimicrobial
4. Celsis Launches RapiScreen(TM) Beverage Microbial Screening System
5. Peramivir Phase 2 Data for the Treatment of Outpatient Influenza to be Presented at the 48th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy
6. 90 billion tons of microbial organisms live in the deep biosphere
7. Microtest Labs Doubles Microbial Identification, Analytical Services
8. Advanced Analytical Unveils New Instrument for Rapid Microbial Identification at BIO 2008
9. Microbia Announces Name Change to Ironwood Pharmaceuticals
10. New Microbial Genome-to-Array Service
11. Change in Medicare and Medicaid Legislation Creates Market for Antimicrobial Coatings In the U.S.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/3/2016)... WOODLANDS, Texas , May 3, 2016  Dr. ... certified plastic surgeon in The Woodlands, Texas ... that destroys 24 percent of treated fat cells in ... and woman. Close to 90 percent of Americans report ... treatment options. Nonsurgical fat reduction procedures are a growing ...
(Date:5/2/2016)... ... ... StarNet Communications Corp, ( http://www.starnet.com/ ) a leading publisher of remote Linux ... to its flagship X-Win32 PC X server. The new modules enable X-Win32 to ... over encrypted SSH. , Traditionally, users of PC X servers deploy the XDMCP protocol ...
(Date:4/29/2016)... 2016 According to a ... "Separation Systems for Commercial Biotechnology Market - Global ... 2015 - 2023", the separation systems for commercial ... in 2014 and is projected to expand at ... to reach US$ 19,227.8 Mn in 2023. ...
(Date:4/28/2016)... PUNE, India , April 28, 2016 ... PT, JT, Stirling, and Brayton Cryocoolers), Service (Technical Support, ... Application, and Geography - Global Forecast to 2022", published ... to USD 2.94 Billion by 2022, at a CAGR ... Browse 70 market data Tables and 94 Figures spread ...
Breaking Biology Technology:
(Date:3/3/2016)... Calif. , March 3, 2016  FlexTech, a ... the categories of Innovation, Research & Development, Leadership in ... Leadership. This is the 9 th year of ... group of companies and individuals from past years ... based on a pre-described set of criteria, by a ...
(Date:3/3/2016)... SOTO, Kansas , March 3, 2016 ... Oncimmune,s Early CDT®-Lung, a blood test to aid ... cancer Early CDT®-Lung test to its clients ... Early CDT®-Lung test to its clients which include ... a leader in early cancer detection, today announced a ...
(Date:3/2/2016)... , March 2, 2016 ... of the "Global Biometrics as a ... offering. --> http://www.researchandmarkets.com/research/cmt3hk/global_biometrics ) ... "Global Biometrics as a Service Market 2016-2020" ... --> Research and Markets ( http://www.researchandmarkets.com/research/cmt3hk/global_biometrics ...
Breaking Biology News(10 mins):